Breaking Silence Through Story: A Narrative Medicine Intervention for Parents of Children With Urogenital Conditions
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Narrative Medicine Journaling Intervention.
- Who it may be relevant to
- Registry conditions: DSD, Hypospadias. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- United States
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Overview
The goal of this clinical trial is to learn whether a journaling intervention can reduce stress and anxiety in parents of children with urogenital conditions (such as differences of sex development and hypospadias). The main questions it aims to answer are: * Does guided journaling help to reduce anxiety levels in parents of children with urogenital conditions? * What are parents' perspectives on group-based writing interventions for future support programs? Participants will: * Complete a short anxiety questionnaire (the General Anxiety Disorder-7 scale) at the beginning of the study * Receive a physical journal with 5 writing prompts designed to help process emotions related to their child's condition * Complete 5 journal entries over several weeks, writing about their experiences and feelings * Complete the same anxiety questionnaire again after finishing the journal entries * Participate in a 45-minute interview to discuss how the journaling affected their stress levels and gather feedback on potential group-based writing programs
Interventions
- Behavioral Narrative Medicine Journaling Intervention
Participants will complete the GAD-7 anxiety assessment at baseline. They will then receive a physical journal containing 5 structured, therapeutic writing prompts designed to help process emotions related to their child's diagnosis. Prompts focus on processing experiences with diagnosis, addressing uncertainty, coping with stigma, and developing resilience. Parents will be instructed to complete the 5 journal entries, spending 15-20 minutes on each writing session at least once per week. Follow
Primary outcome measures
- Change in GAD-7 Anxiety Scores [Time frame: Change from baseline (pre-intervention) to approximately 6 weeks post-intervention initiation]
Secondary outcome measures (4)
- Qualitative Assessment of Anxiety Related to Child's Diagnosis [Time frame: Measured at one follow-up interview, approximately 6 weeks after intervention initiation]
- Changes in Parental Coping Strategies [Time frame: Measured at one follow-up interview, approximately 6 weeks after intervention initiation]
- Interest in Group-Based Writing Interventions [Time frame: Approximately 6 weeks after intervention initiation]
- Feasibility and Acceptability of Journaling Intervention [Time frame: Approximately 6 weeks after intervention initiation]
Eligibility criteria
Inclusion criteria
- Parent or legal guardian of a child (age 0-17 years) diagnosed with a urogenital condition (such as differences of sex development or hypospadias)
- Able to read and understand English
- Willing to complete a guided journaling intervention (through writing or dictation) over a period of approximately 5 weeks
- Willing to participate in a 45 minute follow-up interview
- Able to provide informed consent
Exclusion criteria
- Parent/guardian with severe psychiatric disorder that would interfere with participation as determined by referring physician
- Parent/guardian unable to complete either written journaling activities or dictation
- Inability to provide informed consent
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: Yes
Study design
- Allocation
- N/A
- Model
- Single group
- Masking
- Open label
- Primary purpose
- Supportive care
Study locations
United States · 1 center
- Boston Children's Hospital — Boston
Identifiers
NCT: NCT06989593 · IRB-P00051291 · 89676